Report cover image

Blood Cancer Therapeutics: Global Markets to 2030

Publisher BCC Research
Published Jul 15, 2026
Length 214 Pages
SKU # WA21411934

Description

Report Scope

This report analyzes market trends for blood cancer therapeutics, providing data from 2024, 2025 estimates, compound annual growth rate projections through 2030 (forecast period: 2025-2030), and regional markets. It covers the market potential, competitive environment, regulatory scenarios, drivers, restraints, and opportunities, as well as market projections for 2030 and market share for key companies.

The market scope in this report is segmented by type into leukemia, lymphoma, multiple myeloma, and rare blood disorders. Leukemia is further subdivided into acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous (myeloid) leukemia (AML), and chronic myelogenous (myeloid) leukemia (CML). Lymphoma is further subdivided into non-Hodgkin lymphoma and Hodgkin lymphoma. Rare blood disorders include myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs).

The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment will provide a detailed analysis of major countries, including the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided for 2024 as the base year, with forecasts for 2025 and a 2030 forecast value.

The report aims to:
  • Analyze types of blood cancer therapeutics.
  • Analyze global market size and segmentation.
  • Understand market constraints and drivers.
  • Provide detailed market forecasts for 2030.
  • Assess market shares, competitiveness, and industry structure.
  • Identify potential long-term impacts on the blood cancer therapeutics market.
Report Includes
  • 88 data tables and 63 additional tables
  • An overview and analysis of the global blood cancer therapeutics market
  • Analyses of global market trends, with revenue data for 2024, estimates for 2025, and projections of CAGRs through 2030
  • Estimates of the current market size and growth prospects, with a market share analysis by cancer type, therapeutic class, and region
  • Facts and figures related to market dynamics, including key drivers, restraints, challenges, and opportunities
  • Review of macroeconomic factors and insights derived from Porter's Five Forces analysis
  • Overview of the regulatory landscape across North America, Europe, and Asia-Pacific
  • Discussion of emerging technologies and developments, including clinical trials, pipeline analysis, and patent activity
  • Detailed market analysis by blood cancer type, including leukemia, lymphoma, and multiple myeloma
  • Regional market analysis covering North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with country-level data
  • Analysis of the competitive landscape, including company share analysis and strategic initiatives
  • Company profiles of major players within the industry, including Johnson & Johnson, Bristol-Myers Squibb Co., AbbVie Inc., Novartis AG, and F. Hoffmann-La Roche Ltd.

Table of Contents

214 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factor Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditure
Impact of Global Economic Growth (GDP) on the Pharma Sector
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rise in Blood Cancer Cases
Increasing Burden of Blood Cancers
Rising R&D Investment Among Companies in the Market
Increase in Government Funding and Pharmaceutical R&D Expenditures
Market Restraints
Rising Generic Competition and Patent Expiration
Availability of Affordable Chemotherapeutics Restricts Growth of Advanced Therapies
High Cost of Blood Cancer Therapeutics
Market Opportunities
Potential of Blood Cancer Therapeutics
Emerging Markets
Technological Advances in Drug Manufacturing
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
Overview
Artificial Intelligence (AI)
Antibody-Modified Nanosystems
Targeted Drug Delivery
Clinical Trial Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Key Takeaways
Patent Analysis
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Blood Cancer Therapeutics, by Cancer Type
Key Takeaways
Lymphoma
Leukemia
Multiple Myeloma
Rare Blood Cancers
Global Market for Blood Cancer Therapeutics, by Therapeutic Type
Key Takeaways
Targeted Therapy
Immunotherapy
Chemotherapy
Geographic Breakdown
Global Market for Blood Cancer Therapeutics, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
Middle East
South America
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBVIE INC.
AMGEN INC.
AMNEAL PHARMACEUTICALS LLC.
ASTRAZENECA
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GSK PLC.
JAZZ PHARMACEUTICALS INC.
JOHNSON & JOHNSON
LILLY USA LLC
MERCK & CO. INC.
NOVARTIS AG
REGENERON PHARMACEUTICALS INC.
SANOFI

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us